Primary glomerulonephritides (GN) Miroslav Merta Klinika nefrologie 1. LF a VFN.
AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.
-
Upload
robert-wilkinson -
Category
Documents
-
view
215 -
download
1
Transcript of AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.
![Page 1: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/1.jpg)
AFFECTIVE DISORDERSLONG-TERM TREATMENT OF
DEPRESSION
PROF. MUDr. JIŘÍ RABOCH
1.LF UK A VFN
PRAHA
![Page 2: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/2.jpg)
AFFECTIVE DISORDERSin the history
• 4. b.c. Hippokrates - melancholy, mania• 1899 Kraepelin manic depressiv psychosis• 1953 Kleist, Leonhard - unipolar x bipolar
depression
![Page 3: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/3.jpg)
Paradigms of depression and its treatment
duration treatment
start of 20th cent. long-term long-term
1960 - 1970 short-term short-term
1980 - 1990 long-term long-term
1990 long-term short- and long-term
(Hirschfeld, R.M.A.,1998)
![Page 4: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/4.jpg)
THE GLOBAL BURDEN OF DISEASE
Ch.J.L.MURRAY, A.D.LOPEZ, 1997
HARVARD SCHOOL OF PUBLIC HEALTH
WORLD HEALTH ORGANISATION
WORLD BANK
![Page 5: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/5.jpg)
DALY - Disability Adjusted Life Years
DALY = YLL + YLD
YLL - Years of Life Lost
YLD - Years Lived with Disability
![Page 6: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/6.jpg)
% DALY OF NEUROPSYCHIATRIC DISORDERS IN VARIOUS PARTS OF THE WORLD
0
5
10
15
20
25
30
DALY
mark.ec.
form.soc.
lat.Am.
China
Asia
Med.Sea
subsah.Afr.
Disability Adjusted Life Years Murray a Lopez, 1997
![Page 7: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/7.jpg)
10 MAIN CAUSES OF DEATHestablished market economies
0
2000
4000
6000
8000
10000
12000
14000
16000
YLL
IHD
CVD
traf.acc.
lung canc.
selfinf. Inj.
perinat.
resp.inf.
congenit.
colon ca.
stom. Ca.
Years of Life Lost Murray a Lopez, 1997
![Page 8: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/8.jpg)
10 MAIN CAUSES OF DISABILITIES established market economies
0100020003000400050006000700080009000
10000
YLD
depr.
alcohol
osteoart.
dementia
sch
bp
CVD
OCD
traf.acc.
diabetes
Murray a Lopez, 1997Years Lived with Disability
![Page 9: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/9.jpg)
DALY (%)world
1. Respiratory infections 8,2
2. Diarhoea 7,2
3. Perinatal conditions 6,7
4. Major depression 3,7
5. IHD 3,4
6. CVD 2,8
7. Tuberculosis 2,8
8. Measles 2,7
9. Traffic accidents 2,5
10. Congenital anomalies 2,4
Murray a Lopez, 1997
![Page 10: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/10.jpg)
DALY (%) established market economies
1. 9,9
2. Major depression 6,1
3. CVD 5,9
4. Traffic accidents 4,4
5. Alcohol use 4,0
6. Osteoarthritis 2,9
7. Trachea, bronchus, lung cancers 2,9
8. Dementias 2,7
9. Self-inflicted injuries 2,3
10. Congenital anomalies 2,2
Murray a Lopez, 1997
![Page 11: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/11.jpg)
DALY (%) established market economies age 15 -
441. Major depression 12,3
2. Alcohol use 8,9
3. Traffic accidents 8,5
4. Schizophrenia 5,0
5. Self-inflicted injuries 4,2
6. Bipolar disorder 3,7
7. Drug use 2,9
8. OCD 2,7
9. Osteoarthritis 2,7
10. Violence 2,4Murray a Lopez, 1997
![Page 12: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/12.jpg)
DALYformerly socialist countries
0
500
1000
1500
2000
2500
depr.male depr.female dem.male dem.female
1990
2000
2010
2020
Murray a Lopez, 1997
![Page 13: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/13.jpg)
LIFE-TIME PREVALENCE (%)NCS
TOTAL Men Women
Affective disorders
17,1 12,7 21,7
Anxiety disorders 24,9 19,2 30,5
Dependencies 26,6 35,4 17,9
Non-affektive psychoses
0,7 0,6 0,8
Mental disorders 48,0 48,7 47,3
Kessler, 1994
![Page 14: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/14.jpg)
0
10
20
30
40
50
60
70
80
90
100
0 5 15 25 35 45 55 65 75
AGE OF ONSET OF DEPRESSION
CU
MU
LA
TIV
E F
RE
QU
EN
CY
Cumulative frequency of depression according to the decade of birth and the age at the start of the disease
ECA study
1955+
1945-19541935-1944
1925-1934
1915-1924
1905-1914
1905
Wittchen et al., 1994
![Page 15: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/15.jpg)
FIRST OUT-PATIENT PSYCHIATRIC EVALUATION DURING A YEAR
(2 450 106 EVALUATIONS)
DIAGNOSIS 1994 2003 CHANGES (%)
ORGANIC DISORDERS 27 421 45 083 64,4
DEPENDENCIES 31 097 34 484 10,9
SCHIZOPHRENIA 33 805 37 987 12,4
AFFECTIVE DISORDERS 37 915 79 215 108,9
NEUROTIC DISORDERS 103 577 158 168 52,7
CHILDRENS MENTAL DISORDERS
23 460 21 162 -9,8
TOTAL 307 877 419 175 36,2
ÚZIS 2005
![Page 16: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/16.jpg)
13
28
43
52
5962
66 6871
74 7580 81 82 82
87
0
20
40
60
80
100
0,5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
CUMULATIVE FREQUENCY OF RELAPSES OF DEPRESSION
(378 patients with depressive disorder)
years
Cu
mla
tive
fre
qu
ency
(%
)
Rothschild, A. J., 1999)
![Page 17: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/17.jpg)
LONG-TERM COURSE OF DEPRESSION
bez suic.
úvahy suic.
suicidium
2/3 suicidal ideas
7 – 15 % commits suicide
Keller a Sadock, 1991
![Page 18: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/18.jpg)
NUMBER OF COMMITED SUICIDES/100 000
0
10
20
30
40
50
60
70
80
Rus. Hun Franc. ČR GB Gree.
male
female
WHO 2000
![Page 19: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/19.jpg)
0
5
10
15
20
25
30
35
67 70 73 76 79 82 85 88 91 94 97 0
MUŽI
ŽENY
COMITTED SUICIDESCZECH REPUBLIC
/100 000
ÚZIS 2003
![Page 20: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/20.jpg)
CZECH REPUBLIC
2002 - COMMITED SUICIDES 1483 (1 173 men a 310 women)
ÚZIS 2003
![Page 21: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/21.jpg)
FACTORS INFLUENCING THE COURSE OF DEPRESSION
• GENETIC RISK• AGE AT THE START OF DEPRESSION (<25, 60<)• NUMBER OF PREVIOUS EPIZODES AND THEIR LENGTH• REZIDUAL SYMPTOMS• COMORBIDITY• FEMALE GENDER• PSYCHOSOCIAL SITUATION (PARTNER)• BIOLOGICAL FACTORS – SLEEP PATTERN, HHA ACTIVITY
![Page 22: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/22.jpg)
PHASES OF DEPRESSION TREATMENT
(Kupfer, 1991)
time
Depre
ssio
n inte
nsi
ty
acute continuing maintenance
![Page 23: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/23.jpg)
DEPRESSION TREATMENT OPTIONS
• ANTIDEPRESSANTS, OTHER DRUGS • PSYCHOTHERAPY (KBT, IPT)• OTHER BIOLOGICAL METHODS
ECT
rTMS
PHOTOTHERAPY
SLEEP DEPRIVATION
VNS, DBS
![Page 24: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/24.jpg)
PHASES OF DEPRESSION TREATMENT
(Kupfer, 1991)
time
Depre
ssio
n inte
nsi
ty
acute continuing maintenance
![Page 25: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/25.jpg)
FINISHING THE CONTINUING TREATMENT PHASE
• 4 – 9 MONTHS OF EUTHYMIA• NOT FULFILLING THE CRITERIA FOR
MAINTENANCE TREATMENT• THE PATIENT IS ASKING FOR
• DISCONTINUATION SYNDROM – TCA, SSRI WITH SHORT-TERM ELIMINATION HALF-TIME
• SLOWLY DECREASING THE DAILY DOSAGE - 25 % DD PER MONTH
![Page 26: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/26.jpg)
PHASES OF DEPRESSION TREATMENT
(Kupfer, 1991)
time
Depre
ssio
n inte
nsi
ty
acute continuing maintenance
![Page 27: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/27.jpg)
MAINTENANCE THERAPY
Number of previous epizodes Clinical characteristics biological characteristics
- 3 or more previous suicide sleep pattern epizodes farmacoresistency - one previous epizode psychotic depression HHA activity with special clinical somatic features characteristics difficult psychosocial
situationdouble depression
Maixner a Greden, 1998
![Page 28: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/28.jpg)
MAINTENANCE TREATMENT(LONG-TERM)
• WHAT ANTIDEPRESSANT
• WHAT DOSAGE
• HOW LONG
![Page 29: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/29.jpg)
WHAT ANTIDEPRESSANT?
![Page 30: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/30.jpg)
MAINTENANCE TREATMENT(LONG-TERM)
• LITHIUM• CLASSICAL ANTIDEPRESSANTS• IMAO, RIMA• SSRI• OTHER MODERN
ANTIDEPRESSANTS
![Page 31: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/31.jpg)
0
0,2
0,4
0,6
0,8
1
0 10 20 30 40 50 60 70 80 90 100 110
weeks
RESUTLTS OF MAINTENANCE TREATMENT WITH IMIPRAMINE IN 4. AND 5. YEARS IN
COMPARISON WITH PLACEBO
(Kupfer, D.J., et al., 1992)
p<0,006
Imipramin (n=11)
Placebo (n=9)
Cu
mu
lativ
e f
req
ue
ncy
of
pa
tien
ts in
re
mis
sio
ni
![Page 32: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/32.jpg)
SSRIs – inhibition of P450 microsomal enzymes
enzyme citalopram fluoxetine fluvoxamine paroxetine sertraline
CYP1A2 - - +++ - -CYP2D6 + +++ - +++ +CYP3A3/4 ? + ++ - -CYP2C19 ? ++ +++ ? -
? data lacking - no capacity
+ minor capacity ++ less potent
+++ most potent
(Edwards, J.G. a Anderson, I., 1999
![Page 33: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/33.jpg)
POTENTIALLY SERIOUS DRUG INTERACTIONS OF SSRIs
all antikoagulancia zvýšený antikoagulační efekt(warfarin, kumaroly)
all antidepresivaIMAO serotoninergní syndrom(nižší pravděpodobnost u reverzibilních preparátů)Tricyklika zvýšená hladina některých tricyklik
fluoxetine antiarytmikaflecainid zvýšená plasmatická koncentrace
fluoxetine antikonvulziva snižování záchvatového prahufluvoxamine carbamazepin zvýšené plazmatické hladiny
phenytoinall antihistaminika
terfenadin zvýšené riziko arytmiíall lithium CNS toxicitaall sumatriptan CNS toxicitafluoxetinefluvoxamine klozapin zvýšená plazmatická hladina klozapinufluoxetine haloperidol zvýšená plazmatická hladina haloperidoluall ritonavir zvýšení koncentrace SSR1fluvoxamine theophyllin zvýšená plazmatická hladina theophyllinufluoxetine selegilin CNS excitace, hypertenzeall tramadol zvýšené riziko konvulzí
(Edwards, J.G., Anderson, L, 1999)
![Page 34: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/34.jpg)
MAINTENANCE DEPRESSION TREATMENT
• SSRIs > CLASSICAL ANTIDEPRESSANTSSIMILAR EFFECT BETTER TOLERABILITY COMORBID DISORDERS ONCE A DAY DOSAGE
LOW INTOXICATION LETHALITY
• ANDERSON, 1998
![Page 35: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/35.jpg)
HOW LONG?
![Page 36: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/36.jpg)
0,00
0,20
0,40
0,60
0,80
1,00
0 52 104 156 208 260 312 364 416 468 520 572 624 676 728 780
weeks
pat
ien
ts in
rem
issi
on
Recurrences in 105 patients with major depression after 5 years-remission
(Mueller, T.I., et al., 1999)
![Page 37: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/37.jpg)
WHAT DOSAGE?
![Page 38: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/38.jpg)
DOSAGES OF ANTIDEPRESSANTS IN MAINTENANCE TREATMENT OF
DEPRESSION
• IMIPRAMINE – 3-YEARS FOLLOW-UP – 100 mg - 70 % RELAPSES
200 mg - 30 % RELAPSES (FRANK et al., 1993)
• CITALOPRAM 20 i 40 mg EFFECTIVE IN CONTINUING TREATMENT (MONTGOMERY et al., 1993)
• DECREASING THE DOSAGE OF CITALOPRAM FROM 40 TO 20 mg 2-YEARS FOLLOW-UP – 50 % RELAPSES (FRANCINI et al.,1999)
![Page 39: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/39.jpg)
COMPLIANCE
• STRATEGIES FOR IMPROVING
PATIENT – PHYSICIAN RELATIONSHIP
EDUCATIONADEQUATE FARMAKOTHERAPY
Haddad, 2000
![Page 40: AFFECTIVE DISORDERS LONG-TERM TREATMENT OF DEPRESSION PROF. MUDr. JIŘÍ RABOCH 1.LF UK A VFN PRAHA.](https://reader036.fdocuments.us/reader036/viewer/2022070407/56649e385503460f94b299d3/html5/thumbnails/40.jpg)
PSYCHOFARMACOLOGICAL THERAPY ONLY 13,4 % OF PEOPLE WITH DEPRESSIVE SYMPTOMS (!!!)
0
10
20
30
40
50
%
% 46 13 12 6 2 20
anxiol.antidep
r.hypn. neurol. other ns
Vaněk, Raboch, Vaněk, 2000